Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide




Tirkkonen T, Heikkilä P, Huupponen R, Laine K

2010

 Journal of Internal Medicine

4

268

4

359

366

8

0954-6820

DOIhttps://doi.org/10.1111/j.1365-2796.2010.02257.x




Last updated on 26/11/2024 08:35:44 PM